title: Fludarabine phosphate: a new active agent in hematologic malignancies.
authors.affiliation: University of Texas M.D. Anderson Cancer Center, Houston 77030.
authors.forename: M J
authors.initials: MJ
authors.lastname: Keating
authors.forename: S
authors.initials: S
authors.lastname: O'Brien
authors.forename: W
authors.initials: W
authors.lastname: Plunkett
authors.forename: L E
authors.initials: LE
authors.lastname: Robertson
authors.forename: V
authors.initials: V
authors.lastname: Gandhi
authors.forename: E
authors.initials: E
authors.lastname: Estey
authors.forename: M
authors.initials: M
authors.lastname: Dimopoulos
authors.forename: F
authors.initials: F
authors.lastname: Cabanillas
authors.forename: A
authors.initials: A
authors.lastname: Kemena
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
chemical_list: D001084:Vidarabine Phosphate; C042382:fludarabine phosphate